387 related articles for article (PubMed ID: 26339794)
1. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
Frei JC; Kielian M; Lai JR
Virology; 2015 Nov; 485():371-82. PubMed ID: 26339794
[TBL] [Abstract][Full Text] [Related]
2. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
[TBL] [Abstract][Full Text] [Related]
3. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
[TBL] [Abstract][Full Text] [Related]
4. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
[TBL] [Abstract][Full Text] [Related]
5. Combinatorial Resurfacing of Dengue Envelope Protein Domain III Antigens Selectively Ablates Epitopes Associated with Serotype-Specific or Infection-Enhancing Antibody Responses.
Remmel JL; Beauchemin KS; Mishra AK; Frei JC; Lai JR; Bailey-Kellogg C; Ackerman ME
ACS Comb Sci; 2020 Sep; 22(9):446-456. PubMed ID: 32574486
[TBL] [Abstract][Full Text] [Related]
6. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
7. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
de Alwis R; Smith SA; Olivarez NP; Messer WB; Huynh JP; Wahala WM; White LJ; Diamond MS; Baric RS; Crowe JE; de Silva AM
Proc Natl Acad Sci U S A; 2012 May; 109(19):7439-44. PubMed ID: 22499787
[TBL] [Abstract][Full Text] [Related]
8. Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design.
Li XQ; Qiu LW; Chen Y; Wen K; Cai JP; Chen J; Pan YX; Li J; Hu DM; Huang YF; Liu LD; Ding XX; Guo YH; Che XY
J Gen Virol; 2013 Oct; 94(Pt 10):2191-2201. PubMed ID: 23851440
[TBL] [Abstract][Full Text] [Related]
9. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
[TBL] [Abstract][Full Text] [Related]
10. Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
Gallichotte EN; Baric TJ; Yount BL; Widman DG; Durbin A; Whitehead S; Baric RS; de Silva AM
PLoS Pathog; 2018 Feb; 14(2):e1006934. PubMed ID: 29481552
[TBL] [Abstract][Full Text] [Related]
11. Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
Brien JD; Austin SK; Sukupolvi-Petty S; O'Brien KM; Johnson S; Fremont DH; Diamond MS
J Virol; 2010 Oct; 84(20):10630-43. PubMed ID: 20702644
[TBL] [Abstract][Full Text] [Related]
12. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
[TBL] [Abstract][Full Text] [Related]
13. Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
Swanstrom JA; Nivarthi UK; Patel B; Delacruz MJ; Yount B; Widman DG; Durbin AP; Whitehead SS; De Silva AM; Baric RS
J Infect Dis; 2019 Jun; 220(2):219-227. PubMed ID: 30895307
[TBL] [Abstract][Full Text] [Related]
14. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.
Tsai WY; Chen HL; Tsai JJ; Dejnirattisai W; Jumnainsong A; Mongkolsapaya J; Screaton G; Crowe JE; Wang WK
J Virol; 2018 Dec; 92(23):. PubMed ID: 30185598
[TBL] [Abstract][Full Text] [Related]
15. Recognition determinants of broadly neutralizing human antibodies against dengue viruses.
Rouvinski A; Guardado-Calvo P; Barba-Spaeth G; Duquerroy S; Vaney MC; Kikuti CM; Navarro Sanchez ME; Dejnirattisai W; Wongwiwat W; Haouz A; Girard-Blanc C; Petres S; Shepard WE; Desprès P; Arenzana-Seisdedos F; Dussart P; Mongkolsapaya J; Screaton GR; Rey FA
Nature; 2015 Apr; 520(7545):109-13. PubMed ID: 25581790
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.
Gromowski GD; Barrett ND; Barrett AD
J Virol; 2008 Sep; 82(17):8828-37. PubMed ID: 18562544
[TBL] [Abstract][Full Text] [Related]
17. Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies.
Young E; Carnahan RH; Andrade DV; Kose N; Nargi RS; Fritch EJ; Munt JE; Doyle MP; White L; Baric TJ; Stoops M; DeSilva A; Tse LV; Martinez DR; Zhu D; Metz S; Wong MP; Espinosa DA; Montoya M; Biering SB; Sukulpolvi-Petty S; Kuan G; Balmaseda A; Diamond MS; Harris E; Crowe JE; Baric RS
Cell Host Microbe; 2020 May; 27(5):710-724.e7. PubMed ID: 32407709
[TBL] [Abstract][Full Text] [Related]
18. Antibody recognition of HIV and dengue glycoproteins.
Krauss IJ
Glycobiology; 2016 Aug; 26(8):813-9. PubMed ID: 26941393
[TBL] [Abstract][Full Text] [Related]
19. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism.
Thullier P; Demangel C; Bedouelle H; Mégret F; Jouan A; Deubel V; Mazié JC; Lafaye P
J Gen Virol; 2001 Aug; 82(Pt 8):1885-1892. PubMed ID: 11457994
[TBL] [Abstract][Full Text] [Related]
20. Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
VanBlargan LA; Milutinovic PS; Goo L; DeMaso CR; Durbin AP; Whitehead SS; Pierson TC; Dowd KA
J Virol; 2021 Nov; 95(23):e0095621. PubMed ID: 34549976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
